[1]张建祥),王 方),袁 博),等.乳腺癌FHIT表达及其临床价值的meta分析[J].郑州大学学报(医学版),2017,(06):761-765.[doi:10.13705/j.issn.1671-6825.2017.06.024]
 ZHANG Jianxiang),WANG Fang),YUAN Bo),et al.Expression and clinical significance of FHIT in breast cancer:a meta analysis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(06):761-765.[doi:10.13705/j.issn.1671-6825.2017.06.024]
点击复制

乳腺癌FHIT表达及其临床价值的meta分析()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2017年06期
页码:
761-765
栏目:
应用研究
出版日期:
2017-11-15

文章信息/Info

Title:
Expression and clinical significance of FHIT in breast cancer:a meta analysis
作者:
张建祥1)王 方2)袁 博2)周亚楠2)胡 泷2)姜文静2)宗 红2)#
1)郑州大学第一附属医院普外科 郑州 450052
2)郑州大学第一附属医院肿瘤科 郑州 450052
Author(s):
ZHANG Jianxiang1) WANG Fang2) YUAN Bo2) ZHOU Yanan2) HU Shuang2) JIANG Wenjing2) ZONG Hong2)
1)Department of General Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052
2)Department of Oncology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052
关键词:
乳腺癌 FHIT meta分析 病例对照研究
Keywords:
breast neoplasm FHIT meta-analysis case-control study
分类号:
R737.9
DOI:
10.13705/j.issn.1671-6825.2017.06.024
摘要:
目的:系统评价FHIT蛋白在乳腺癌中的表达及临床意义。方法:检索中国知网、万方数据、维普网、Pubmed、SpringerLink等数据库,按照纳入、排除标准选取文献,应用RevMan 5.3.5.0及STATA 13.0软件对纳入的研究进行meta分析。结果:共纳入29篇文献,共计2 546例乳腺癌组织标本。Meta分析结果显示,乳腺癌组织中FHIT的表达低于乳腺良性病变组织[OR(95%CI)=0.12(0.06,0.23)]、癌旁正常组织[OR(95%CI)=0.05(0.02,0.11)]和正常组织[OR(95%CI)=0.06(0.02,0.14)]; FHIT在乳腺癌Ⅰ-Ⅱ期中的表达高于Ⅲ-Ⅳ期[OR(95%CI)=2.51(1.87,3.38)]、肿瘤长径小于等于2 cm组高于大于2 cm组[P<0.01,OR=1.43,95%CI(1.10,1.84)]、高分化组高于低分化组[OR(95%CI)=2.18(1.33,3.57)]、无腋窝淋巴结转移组高于有转移组[OR(95%CI)=2.24(1.58,3.16)]、雌激素受体阴性组低于阳性组[OR(95%CI)=0.46(0.34,0.62)]、孕激素受体阴性组低于阳性组[OR(95%CI)=0.51(0.30,0.86)],患者不同年龄、绝经状态和组织分型中FHIT的表达差异无统计学意义。结论:FHIT表达缺失在乳腺癌发生、发展中起重要作用,与乳腺癌的临床病理特征有密切关系。
Abstract:
Aim: To systematic evaluate the expression and clinical significance of FHIT in breast cancer.Methods: Literatures were searched in databases such as CNKI, Wanfang data, Weipu data, Pubmed and SpringerLink. According to the inclusion and exclusion criteria, data were extracted. Then the data were analyzed by RevMan 5.3.5.0 and STATA 13.0 software.Results: A total of 29 literatures with 2 546 breast cancer tissue specimens were included. It was showed that the expression of FHIT was significantly different between breast cancer versus benign breast disease [OR(95%CI)=0.12(0.06,0.23)], breast cancer versus normal tissue adjacent to cancer [OR(95%CI)=0.05(0.02,0.11)], breast cancer versus normal tissue [OR(95%CI)=0.06(0.02,0.14)],stageⅠ-Ⅱ versus stage Ⅲ-Ⅳ [OR(95%CI)=2.51(1.87,3.38)],size≤2 cm versus size>2 cm [OR(95%CI)=1.43(1.10,1.84)],SBR 1-2 versus SBR 3 [OR(95%CI)=2.18(1.33,3.57)], lymph node negative versus positive [OR(95%CI)=2.24(1.58,3.16)], ER negative versus positive [OR(95%CI)=0.46(0.34,0.62)], PR negative versus positive [OR(95%CI)=0.51(0.30,0.86)]. There were no significant differences between age<50 years versus age≥50 years, pre-menopausal versus post-menopausal, ductal versus lobular.Conclusion: Reduced expression of FHIT is closely related to carcinogenesis and progression of breast cancer. FHIT is closely related to the clinical and pathological characteristics of breast cancer.

参考文献/References:

[1] TORRE LA,BRAY F,SIEGEL RL,et al.Global Cancer Statistics, 2012[J].CA Cancer J Clin,2015,65(2):87
[2] 曹志宇,何建苗,杨波,等.局部晚期乳腺癌新辅助化疗联合保乳手术的临床疗效观察:附81例报告[J].解放军医学杂志,2015,40(6):488
[3] ARUN B,KILIC G,YEN C,et al.Loss of FHIT expression in breast cancer is correlated with poor prognostic markers[J].Cancer Epidemiol Biomarkers Prev,2005,14(7):1681
[4] GATALICA Z,LELE SM,RAMPY BA,et al.The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma[J].Cancer,2000,88(6):1378
[5] GINESTIER C,BARDOU VJ,POPOVICI C,et al.Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer[J].Int J Cancer,2003,107(5):854
[6] GULER G,UNER A,GULER N,et al.The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma[J].Cancer,2004,100(8):1605
[7] JEONG YJ,JEONG HY,LEE SM,et al.Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients[J].Oncol Rep,2013,30(5):2270
[8] TERRY G,HO L,LONDESBOROUGH P,et al.The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions[J].Br J Cancer,2007,96(1):110
[9] WANG TT,FREZZA EE,MA R,et al.Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities[J].Chin Med J(Engl),2008,121(20):1969
[10]WANG ZB,ZHAO P,LIU M,et al.Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof[J].Zhonghua Yi Xue Za Zhi,2006,86(31):2171
[11]YANG Q,YOSHIMURA G,SUZUMA T,et al.Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma[J].Clin Cancer Res,2001,7(12):3869
[12]曹友德,李圆园,齐荣华.VEGF-C、Fhit在乳腺癌中的表达及其与淋巴结转移的关系[J].实用肿瘤杂志,2003,18(3):206
[13]陈凌,银平章,孔令非,等.乳腺癌组织FHIT基因位点杂合性缺失及其蛋白表达的研究[J].实用诊断与治疗杂志,2004,18(2):109
[14]陈勇,郭伟,李洪涛.抑癌基因PTEN和FHIT在乳腺癌中的表达及意义[J].中华全科医学,2013,11(12):1847
[15]丁宇.FHIT基因在乳腺癌和癌旁组织中的表达与临床分期、淋巴结转移及数量、激素受体的相关性研究[D].济南:山东大学,2003.
[16]杜洪,梁颜笑,李雯,等.抑癌基因FHIT在乳腺癌中的表达及意义[J].中国医师杂志,2006(S1):47
[17]韩娜娜,薛峰,马斌林.乳腺浸润性导管癌患者中Fhit基因的表达及其与雌、孕激素受体表达的相关性[J].新疆医科大学学报,2008,31(3):280
[18]郝志伟,田珊,李雪艳,等.FHIT蛋白在乳腺癌中表达的研究[J].中国现代普通外科进展,2015,18(4):292
[19]金春亭,李海军,张林西,等.FHIT抑癌基因在乳腺癌组织中的表达缺失[J].河北北方学院学报(医学版),2007,24(1):14
[20]景洪标.乳腺癌中FHIT基因异常和肌上皮细胞免疫标记物的研究[D].重庆:第三军医大学,2005.
[21]刘英伟.FHIT、ki-67在乳腺癌中的表达及临床病理学意义[D].佳木斯:佳木斯大学,2007.
[22]吕文红.乳腺浸润性导管癌Fhit、C-erbB-2基因蛋白的表达及其临床意义[D].泰安:泰山医学院,2012.
[23]聂向荣.乳腺癌组织中p27表达与FHIT表达相关性及两者与乳腺癌临床、病理关系的研究[D].石家庄:河北医科大学,2005.
[24]欧应登.Fhit和CerbB-2在乳腺癌进展过程中的表达和意义[J].中国中医药现代远程教育,2010,8(11):256
[25]戚雯琰,周冬根,何文,等.乳腺癌脆性组氨酸三联体表达及其与体外药敏的相关性研究[J].江西医药,2013,48(11):1028
[26]邵霞.FHIT、CXCR4及CD82在乳腺癌中的表达及临床意义研究[D].苏州:苏州大学,2007.
[27]唐峰,顾栋桦,王虹,等.FHIT蛋白在乳腺癌进展过程中的表达[J].复旦学报(医学版),2004,31(3):225
[28]王富文,徐国萍,应学翔,等.FHIT在乳腺癌中的表达及其与临床病理指标的关系[J].实用癌症杂志,2011,26(4):368
[29]王世东.乳腺癌组织中脆性组氨酸三联体基因的表达及意义[J].中国医药,2009,4(9):697
[30]张浩,僧靖静,赵玉亭,等.乳癌组织中脆性组氨酸三联体蛋白检测[J].郑州大学学报(医学版),2007,42(1):137
[31]赵典朋,贾丽燕,刘桂玲,等.乳腺癌中脆性组氨酸三联体异常甲基化能下调其mRNA及蛋白的表达[J].中华乳腺病杂志:电子版,2012,6(1):32
[32]SYEED N,HUSAIN SA,SAMEER AS,et al.Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir[J].Mutat Res,2011,707(1/2):1
[33]ISMAIL HM,MEDHAT AM,KARIM AM,et al.Multiple Patterns of FHIT Gene Homozygous Deletion in Egyptian Breast Cancer Patients[J].Int J Breast Cancer,2011,2011:325947
[34]ISMAIL HM,MEDHAT AM,KARIM AM,et al.FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients[J].Mol Carcinog,2011,50(8):625
[35]ZAKI SM,ABDEL-AZEEZ H,EL NM,et al.Analysis of FHIT gene methylation in Egyptian breast cancer women:association with clinicopathological features[J].Asian Pac J Cancer Prev,2015,16(3):1235

相似文献/References:

[1]李诗竹,齐心月,吕晓华#.腌制及烟熏食品与乳腺癌发病风险关系的meta分析[J].郑州大学学报(医学版),2016,(01):122.
 LI Shizhu,QI Xinyue,LYU Xiaohua.Meta analysis of relationship between pickled and smoked food and onset risk of breast cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2016,(06):122.
[2]刘 莹),王圆圆),贾文青),等.肺癌患者血清p16、FHIT、APC基因甲基化检测*[J].郑州大学学报(医学版),2017,(01):51.[doi:10.13705/j.issn.1671-6825.2017.01.014]
 LIU Ying),WANG Yuanyuan),JIA Wenqing),et al.Determination of p16, FHIT and APC gene methylation in serum from patients with lung cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(06):51.[doi:10.13705/j.issn.1671-6825.2017.01.014]
[3]田延锋△,李 芳,刘 擘,等.MiR-214对人乳腺癌MCF-7细胞生物学行为的影响*[J].郑州大学学报(医学版),2017,(01):88.[doi:10.13705/j.issn.1671-6825.2017.01.023]
 TIAN Yanfeng,LI Fang,LIU Bo,et al.Effect of miR-214 on biological function in breast cancer MCF-7 cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(06):88.[doi:10.13705/j.issn.1671-6825.2017.01.023]
[4]杨 志,李 宁,廖光星,等.乳腺癌原发灶弥散加权成像在预测腋窝淋巴结转移中的应用价值*[J].郑州大学学报(医学版),2017,(04):448.[doi:10.13705/j.issn.1671-6825.2017.04.018]
 YANG Zhi,LI Ning,LIAO Guangxing,et al.Predictive value of diffusion weighted imaging of primary foci in cases of breast cancer with axillary lymph node metastasis[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(06):448.[doi:10.13705/j.issn.1671-6825.2017.04.018]
[5]刘高秀),李文涛),吴凯彦),等.乳腺原发性血管肉瘤一例[J].郑州大学学报(医学版),2018,(03):399.[doi:10.13705/j.issn.1671-6825.2017.09.149]
[6]蒋淑敏,孙长青,张晓星,等.河南省某三甲医院乳腺癌手术患者住院费用影响因素分析[J].郑州大学学报(医学版),2018,(04):477.[doi:10.13705/j.issn.1671-6825.2017.11.119]
 JIANG Shumin,SUN Changqing,ZHANG Xiaoxing,et al.Influential factors of hospitalization costs in patients with breast cancer surgery at a tertiary hospital in Henan Province[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2018,(06):477.[doi:10.13705/j.issn.1671-6825.2017.11.119]

备注/Memo

备注/Memo:
#通信作者,女,1968年4月生,博士,主任医师,教授,研究方向:消化道肿瘤的基础与临床,E-mail:zonghong522@126.com
更新日期/Last Update: 2017-11-20